Advanced search
Publication Cover
Cancer Management and Research Volume 13, 2021 - Issue
Submit an article Journal homepage
111
Views
9
CrossRef citations to date
0
Altmetric
Original Research

Fibrinogen/Albumin Ratio as a Promising Marker for Predicting Survival in Pancreatic Neuroendocrine Neoplasms

Shengming Deng1 Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, People’s Republic of China;2 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of China;3 Shanghai Pancreatic Cancer Institute, Shanghai, People’s Republic of China;4 Pancreatic Cancer Institute, Fudan University, Shanghai, People’s Republic of China
,
Zhiyao Fan1 Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, People’s Republic of China;2 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of China;3 Shanghai Pancreatic Cancer Institute, Shanghai, People’s Republic of China;4 Pancreatic Cancer Institute, Fudan University, Shanghai, People’s Republic of China
,
Huanyu Xia1 Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, People’s Republic of China;2 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of China;3 Shanghai Pancreatic Cancer Institute, Shanghai, People’s Republic of China;4 Pancreatic Cancer Institute, Fudan University, Shanghai, People’s Republic of China
,
Yitao Gong1 Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, People’s Republic of China;2 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of China;3 Shanghai Pancreatic Cancer Institute, Shanghai, People’s Republic of China;4 Pancreatic Cancer Institute, Fudan University, Shanghai, People’s Republic of China
,
Yunzhen Qian1 Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, People’s Republic of China;2 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of China;3 Shanghai Pancreatic Cancer Institute, Shanghai, People’s Republic of China;4 Pancreatic Cancer Institute, Fudan University, Shanghai, People’s Republic of China
,
Qiuyi Huang1 Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, People’s Republic of China;2 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of China;3 Shanghai Pancreatic Cancer Institute, Shanghai, People’s Republic of China;4 Pancreatic Cancer Institute, Fudan University, Shanghai, People’s Republic of China
,
He Cheng1 Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, People’s Republic of China;2 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of China;3 Shanghai Pancreatic Cancer Institute, Shanghai, People’s Republic of China;4 Pancreatic Cancer Institute, Fudan University, Shanghai, People’s Republic of China
,
Kaizhou Jin1 Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, People’s Republic of China;2 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of China;3 Shanghai Pancreatic Cancer Institute, Shanghai, People’s Republic of China;4 Pancreatic Cancer Institute, Fudan University, Shanghai, People’s Republic of China
,
Zhiwen Xiao1 Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, People’s Republic of China;2 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of China;3 Shanghai Pancreatic Cancer Institute, Shanghai, People’s Republic of China;4 Pancreatic Cancer Institute, Fudan University, Shanghai, People’s Republic of China
,
Guopei Luo1 Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, People’s Republic of China;2 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of China;3 Shanghai Pancreatic Cancer Institute, Shanghai, People’s Republic of China;4 Pancreatic Cancer Institute, Fudan University, Shanghai, People’s Republic of China
,
Xianjun Yu1 Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, People’s Republic of China;2 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of China;3 Shanghai Pancreatic Cancer Institute, Shanghai, People’s Republic of China;4 Pancreatic Cancer Institute, Fudan University, Shanghai, People’s Republic of China
&
Chen Liu1 Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, People’s Republic of China;2 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of China;3 Shanghai Pancreatic Cancer Institute, Shanghai, People’s Republic of China;4 Pancreatic Cancer Institute, Fudan University, Shanghai, People’s Republic of ChinaCorrespondence[email protected] [email protected]
 show all
Pages 107-115 | Published online: 08 Jan 2021

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Jiake Xu, Shaochun Li, Ye Feng, Jie Zhang, Youduo Peng, Xiaohong Wang & Hongwei Wang. (2022) The Fibrinogen/Albumin Ratio Index as an Independent Prognostic Biomarker for Patients with Combined Hepatocellular Cholangiocarcinoma After Surgery. Cancer Management and Research 14, pages 1795-1806.
Read now
Chengliang Yuan, Meifang Huang, Huilin Wang, Wei Jiang, Cuiyun Su & Shaozhang Zhou. (2022) Pretreatment Fibrinogen-Albumin Ratio (FAR) Associated with Treatment Response and Survival in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Anti-PD-1 Therapy Plus Platinum-Based Combination Chemotherapy. Cancer Management and Research 14, pages 377-386.
Read now

Articles from other publishers (7)

Chao Deng, Sujuan Zhang, Jie Ling, Zui Chen, Yuhua Feng, Yangchun Xie, Xianling Liu, Chunhong Hu & Tao Hou. (2023) Prognostic value of the fibrinogen albumin ratio index (FARI) in nasopharyngeal carcinoma patients undergoing radiotherapy. Scientific Reports 13:1.
Crossref
Xiao-Jie Zhang, He Fei, Chong-Yuan Sun, Ze-Feng Li, Zheng Li, Chun-Guang Guo & Dong-Bing Zhao. (2023) Novel prognostic score based on the preoperative total bilirubin-albumin ratio and fibrinogen-albumin ratio in ampullary adenocarcinoma. World Journal of Gastrointestinal Surgery 15:10, pages 2247-2258.
Crossref
Chengqing Li, Zhiyao Fan, Wenyi Guo, Feng Liang, Xincheng Mao, Jiahao Wu, Haodong Wang, Jianwei Xu, Dong Wu, Han Liu, Lei Wang & Feng Li. (2023) Fibrinogen-to-prealbumin ratio: A new prognostic marker of resectable pancreatic cancer. Frontiers in Oncology 13.
Crossref
Xiao-Yu Chen, Zhi-Qing Long, Han-Ying Huang, Wen Wen, Fei Lin, Ling Guo & Huan-Xin Lin. (2023) Predicting Survival of Patients with Nonmetastatic Breast Cancer Based on Fibrinogen-to-Albumin Ratio and Lymphocyte-to-Monocyte Ratio: A Nomogram-Based Assessment. Breast Care 18:5, pages 374-389.
Crossref
Wei Chen, Boer Shan, Shuling Zhou, Huijuan Yang & Shuang Ye. (2022) Fibrinogen/albumin ratio as a promising predictor of platinum response and survival in ovarian clear cell carcinoma. BMC Cancer 22:1.
Crossref
Baibei Li, Huachu Deng, Biao Lei, Leijie Chen, Xinyuan Zhang & Dingran Sha. (2022) The prognostic value of fibrinogen to albumin ratio in malignant tumor patients: A meta-analysis. Frontiers in Oncology 12.
Crossref
Xuyang Liu, Zhiyuan Yu, Dingke Wen, Lu Ma & Chao You. (2021) Prognostic value of albumin-fibrinogen ratio in subarachnoid hemorrhage patients. Medicine 100:17, pages e25764.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.